The Press Room

Wayne State University School of Medicine News To enhance the success of advancing the science related to ovarian cancer, the Barbara Ann Karmanos Cancer Institute and Wayne State University’s C.S. Mott Center for Human Growth and Development have established the Ovarian Cancer Research Interest Group. The group seeks to bring together scientists and physicians working in the field to merge each investigator’s individual expertise to rapidly find solutions to confront the disease. Read the full article ...

A team led by Lauren Hamel, Ph.D., assistant professor and member of the Population Studies and Disparities Research Program at the Karmanos Cancer Institute and Wayne State University School of Medicine has identified discernable patterns of behaviors between Black patients with cancer and their oncologists. Read the full article here .

WXYZ Channel 7: Philip A. Philip, M.D., Ph.D, FRCP, discusses signs, symptoms and treatment for pancreatic cancer as this disease’s awareness month comes to a close. View the clip here .

Fox 47 News, Lansing and Jackson To help detect lung cancer at an early stage, Karmanos Cancer Institute at McLaren Greater Lansing offers lung cancer screenings. Read the complete article here .

In light of Al Roker’s recent prostate cancer announcement, Isaac Powell, M.D., member of the Genitourinary Oncology Multidisciplinary Team , discusses prostate cancer in Black men with Kimberly Gill. Their conversation covers the genes responsible for a more aggressive form of prostate cancer, disparities in screening rates, research funding and more. View the story here .

Managed Healthcare Executive Hadeel Assad, M.D. discusses emerging treatments for breast cancer. Read the complete article here .

From Becker’s Healthcare Podcast : Gerold Bepler, M.D., Ph.D., president & CEO of Karmanos Cancer Institute, talks with Scott Becker on Becker’s Healthcare Podcast. They discuss the importance of cancer screening, even during COVID, and Dr. Bepler shares Karmanos’ points of pride, which include the National Cancer Institute (NCI) designation and a wide range of clinical trials. Your browser does not support the audio element. Download Audio

To the community we serve, At Karmanos Cancer Institute, outstanding patient care is at the heart of everything we do, no matter the circumstances. As cases of COVID-19 continue to increase throughout the state of Michigan, we remain committed to your care. We know that cancer isn’t waiting for COVID-19 to pass and we will stand by your side at every step of your journey. We have implemented many new safety measures in response to the pandemic. These include: Screening everyone who enters our facilities...

In an interview with Michigan Oncology Quality Consortium's Ovarian Cancer Education Podcast, Radhika Gogoi, M.D., member of the Gynecologic Multidisciplinary Team at Karmanos, discusses a new diagnosis and the basics of ovarian cancer. "We recommend that all women who are diagnosed with ovarian cancer go through genetic testing to determine whether they carry a gene that puts them at higher risk for ovary and breast cancer. If they are positive, their family members or relatives should also seek geneti...

Trial Site News The Barbara Ann Karmanos Cancer Institute, already a pathbreaker when it comes to working for health equity, has launched the Diversity and Inclusion Committee to integrate best practices, inclusion and cultural competence in an ongoing quest to deliver continuously better and more equitable medical care. Read the complete article here .